Want to join the conversation?
$HCP 2Q15 Call: HCP had $1.1Bil of liquidity from revolver & cash on hand. Fixed charge coverage remained steady at 4.0x. Financial leverage and net debt to EBITDA grew to 45.6% & 6.0 times, respectively. 2015 increased guidance: Expected FFO in range of $1.97-2.03 per share. Adj. FFO range $3.14-3.20 per share. FAD range $2.68-2.74 per share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.